Revisiting the Association Between Metabolic Syndrome and Depressive Symptoms

Annals of Epidemiology

Volumn 20, Issue 11, 2010, Pages 852-855

  Kobrosly, Roni W ^a   van Wijngaarden, Edwin ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Cross sectional studies; Depression; Epidemiology; Metabolic syndrome X; Psychosomatic medicine

Indexed keywords

ANTIDEPRESSANT AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SOCIAL ASPECT; SOCIOECONOMICS; SYMPTOM; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; COMORBIDITY; CONFIDENCE INTERVALS; DEPRESSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; ODDS RATIO; QUESTIONNAIRES; RISK FACTORS; UNITED STATES;

EID: 77957660113     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2010.08.002     Document Type: Article

References (44)

1. Knol M.J., Twisk J.W., Beekman A.T., et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006, 49:837-845.
2. Wickramaratne P.J., Weissman M.M., Leaf P.J., et al. Age, period and cohort effects on the risk of major depression: results from five United States communities. J Clin Epidemiol 1989, 42:333-343.
3. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
4. Ford E.S., Zhao G., Li C., et al. Trends in obesity and abdominal obesity among hypertensive and nonhypertensive adults in the United States. Am J Hypertens 2008, 21:1124-1128.
5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
6. Kopf D., Westphal S., Luley C.W., et al. Lipid metabolism and insulin resistance in depressed patients: Significance of weight, hypercortisolism, and antidepressant treatment. J Clin Psychopharmacol 2004, 24:527-531.
7. McCaffery J.M., Niaura R., Todaro J.F., et al. Depressive symptoms and metabolic risk in adult male twins enrolled in the National Heart, Lung, and Blood Institute twin study. Psychosom Med 2003, 65:490-497.
8. Kinder L.S., Carnethon M.R., Palaniappan L.P., et al. Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 2004, 66:316-322.
9. Skilton M.R., Moulin P., Terra J.L., et al. Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry 2007, 62:1251-1257.
10. Vanhala M., Jokelainen J., Keinanen-Kiukaanniemi S., et al. Depressive symptoms predispose females to metabolic syndrome: A 7-year follow-up study. Acta Psychiatr Scand 2009, 119:137-142.
11. Viinamaki H., Heiskanen T., Lehto S.M., et al. Association of depressive symptoms and metabolic syndrome in men. Acta Psychiatr Scand 2009, 120:23-29.
12. Goldbacher E.M., Bromberger J., Matthews K.A. Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women. Psychosom Med 2009, 71:266-272.
13. Heiskanen T.H., Niskanen L.K., Hintikka J.J., et al. Metabolic syndrome and depression: A cross-sectional analysis. J Clin Psychiatry 2006, 67:1422-1427.
14. Herva A., Rasanen P., Miettunen J., et al. Co-occurrence of metabolic syndrome with depression and anxiety in young adults: The Northern Finland 1966 Birth Cohort Study. Psychosom Med 2006, 68:213-216.
15. Hildrum B., Mykletun A., Midthjell K., et al. No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study. Acta Psychiatr Scand 2009, 120:14-22.
16. Diaz-Martinez L., Serrano N., Pinzon J., et al. [Lack of association between metabolic syndrome and depressive symptoms in Colombian adults]. Rev Med Chil 2007, 135:990-996.
17. Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res 2007, 62:31-38.
18. McIntyre R.S., Rasgon N.L., Kemp D.E., et al. Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Curr Diab Rep 2009, 9:51-59.
19. Survey operations manuals, brochures, and consent documents: 1999-current NHANES Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS)National Center for Health Statistics (NCHS), Available at:, Accessed November 1, 2009. http://www.cdc.gov/nchs/nhanes.htm.
20. National Health and Nutrition Examination Survey Protocol 2009, Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS)National Center for Health Statistics (NCHS), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, MD.
21. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 2001, 16:606-613.
22. Kobrosly R., van Wijngaarden E. Associations between immunologic, inflammatory, and oxidative stress markers with severity of depressive symptoms: An analysis of the 2005-2006 National Health and Nutrition Examination Survey. Neurotoxicology 2010, 31:126-133.
23. Maxwell S.R., Dietrich T., Chapple I.L. Prediction of serum total antioxidant activity from the concentration of individual serum antioxidants. Clin Chim Acta 2006, 372:188-194.
24. Miller N.J., Rice-Evans C., Davies M.J., et al. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 1993, 84:407-412.
25. Lee D.H., Lim J.S., Song K., et al. Graded associations of blood lead and urinary cadmium concentrations with oxidative-stress-related markers in the U.S. population: Results from the third National Health and Nutrition Examination Survey. Environ Health Perspect 2006, 114:350-354.
26. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009, 71:171-186.
27. Hopps E., Noto D., Caimi G., Averna M.R. A novel component of the metabolic syndrome: The oxidative stress. Nutr Metab Cardiovasc Dis 2010, 20:72-77.
28. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65:732-741.
29. Scott S.C., Goldberg M.S., Mayo N.E. Statistical assessment of ordinal outcomes in comparative studies. J Clin Epidemiol 1997, 50:45-55.
30. Potenza M.V., Mechanick J.I. The metabolic syndrome: definition, global impact, and pathophysiology. Nutr Clin Pract 2009, 24:560-577.
31. Bruce K.D., Hanson M.A. The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr 2010, 140:648-652.
32. Newcomer J.W. Metabolic syndrome and mental illness. Am J Manag Care 2007, 13(7 Suppl):S170-S177.
33. Reaven G.M. The metabolic syndrome: Requiescat in pace. Clin Chem 2005, 51(6):931-938.
34. Puenpatom R.A., Victor T.W. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: An analysis of NHANES III data. Postgrad Med 2009, 121:9-20.
35. Garruti G., Depalo R., Vita M.G., et al. Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment. Reprod Biomed Online 2009, 19:552-563.
36. Gangwisch J.E. Epidemiological evidence for the links between sleep, circadian rhythms and metabolism. Obes Rev 2009, 10(Suppl 2):37-45.
37. Vreeburg S.A., Hoogendijk W.J., van Pelt J., et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: Results from a large cohort study. Arch Gen Psychiatry 2009, 66:617-626.
38. Huber T.J., Issa K., Schik G., et al. The cortisol awakening response is blunted in psychotherapy inpatients suffering from depression. Psychoneuroendocrinology 2006, 31:900-904.
39. Marques A.H., Silverman M.N., Sternberg E.M. Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics. Ann N Y Acad Sci 2009, 1179:1-18.
40. Jaffee S.R., Moffitt T.E., Caspi A., et al. Differences in early childhood risk factors for juvenile-onset and adult-onset depression. Arch Gen Psychiatry 2002, 59:215-222.
41. Wott C.B., Carels R.A. Overt weight stigma, psychological distress and weight loss treatment outcomes. J Health Psychol 2010, 15:608-614.
42. Birkenaes A.B., Birkeland K.I., Engh J.A., et al. Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions. J Clin Psychopharmacol 2008, 28:132-137.
43. Lorant V., Deliege D., Eaton W., et al. Socioeconomic inequalities in depression: A meta-analysis. Am J Epidemiol 2003, 157:98-112.
44. Phillips A.C., Carroll D., Thomas G.N., et al. The influence of multiple indices of socioeconomic disadvantage across the adult life course on the metabolic syndrome: the Vietnam Experience Study. Metabolism 2010, 59:1164-1171.